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Derek C. AngusFig. 1 Mitchell P. FinkMitchell P. Fink, MD (Fig. 1), one of the most inspiring
and influential leaders in the field of intensive care medi-
cine, died at 66 years of age on 17 November 2015 after
being diagnosed this summer with an aggressive sar-
coma. This devastating news has left many of us with a
huge sense of loss and sadness.
Mitch graduated from the Washington University
School of Medicine in St. Louis, MO, in 1976 and com-
pleted general surgery training at the National Naval
Medical Center in Bethesda, MD, in 1981. Thereafter, he
held faculty positions at the Bethesda Naval Center
and the University of Massachusetts, where he worked
as surgeon and intensivist. In 1992 he moved to the
Harvard Medical School, eventually becoming the Johnson
and Johnson Professor in Surgery and surgeon-in-chief at
the Beth Israel Deaconess Medical Center. He moved to
the University of Pittsburgh in 1999, where he subse-
quently became the inaugural chair of the Department of
Critical Care Medicine. He founded several companies
based on discoveries from his laboratory and, in 2007, left
the university to oversee the formation of one of these
ventures. In 2009 Mitch returned to academia, joining the
faculty at University of California Los Angeles where he
held the title of Professor of Surgery and Vice Chair for
Critical Care.
During his career, Mitch cared for thousands of pa-
tients with skill and compassion, amassed a great body
of experimental and clinical research, trained and men-
tored hundreds of physicians and scientists, demon-
strated wonderful entrepreneurship, and carved a vision
of modern multidisciplinary critical care with lasting
benefits for our entire field. For decades, academic medi-
cine has praised the rare individual who excels as the so-
called triple threat: teacher, clinician, and scientist. Mitch
was all three and more, adding to these triple roles the
rare gift of visionary leader in both academia and industry.
I have never known anyone quite like Mitch.
His extraordinary career began early with a first author
paper in Nature while still in medical school. WhileCorrespondence: angusdc@upmc.edu
Department of Critical Care Medicine, University of Pittsburgh, 3550 Terrace
Street, 614 Scaife Hall, Pittsburgh, PA 15261, USA
© 2015 Angus. Open Access This article is dis
License (http://creativecommons.org/licenses/
medium, provided you give appropriate credi
Commons license, and indicate if changes we
creativecommons.org/publicdomain/zero/1.0/working in Bethesda, he forged close relationships with
the National Institutes of Health critical care group, con-
ducting a number of seminal experimental studies that
both helped to establish the utility of animal models to
probe the host response to sepsis, trauma, and shock
and to inform our current understanding of these syn-
dromes. Later, Mitch would conduct pioneering work
using cell-based models of organ dysfunction to tease
out the cellular response to stress from hypoxia and
endogenous and exogenous danger signals, exploring
key concepts of mitochondrial dysfunction and dysoxia.
In addition to his passion for experimental research,
Mitch also conducted many highly cited clinical stud-
ies, co-wrote the Textbook of Critical Care, and served
on the editorial boards of numerous journals including
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acteristics: knowledge, logic, creativity, and focus. He
maintained an encyclopedic knowledge of the world,
able to quote relevant papers, data, and information off
the top of his head from a dizzyingly wide range of art,
science, politics, and history. He also exercised crystal-
clear logic, distilling the most complex problem into a
series of simple steps, whether this was a complicated
piece of basic science or a tough business decision facing
a start-up biotechnology company. Having concisely sum-
marized any problem, he then brought great creativity and
inventiveness to probe and tackle its solution. Finally, he
always kept a clear sense of purpose, making sure neither
he nor his colleagues ever lost sight of the larger goals of
advancing medical knowledge and saving lives.
I came to know Mitch during his tenure in Pittsburgh
when he oversaw one of the most prolific and successful
eras in our history, serving as a wonderful mentor and
colleague, and launching the first multidisciplinary de-
partment of critical care medicine in a US medical
school. In our daily contact with Mitch, we saw not only
his intellect and drive, but also his warmth, compassion,
wit, and grace. His door was always open, ready to listen
to everyone from senior colleagues to junior residents
and new staff. He had words of kindness and advice to
coach us through every disappointment and words of
praise and respect for every accomplishment. For me, as
for many, Mitch was unquestionably one of the most
supportive and influential people we have ever known.
Through both his words and actions, he taught us not
just about medicine and science, but about life, relation-
ships, honor, duty, and service. We have lost an im-
mense presence. Mitch is survived by his wife, Judy, and
children, Matt and Emily. We extend our deepest con-
dolences to them. He will be deeply missed.
